Literature DB >> 15988471

Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area.

Nicole M Vittoz1, Craig W Berridge.   

Abstract

Hypocretins (HCRTs) modulate a variety of behavioral and physiological processes, in part via interactions with multiple ascending modulatory systems. Further, HCRT efferents from the lateral hypothalamus innervate midbrain dopamine (DA) nuclei, and DA cell bodies express HCRT receptors. Combined, these observations suggest that HCRT may influence behavioral state and/or state-dependent processes via modulation of DA neurotransmission. The current studies used in vivo microdialysis in the unanesthetized rat to first characterize the effect of intracerebroventricular infusion of HCRT-1 (0.07, 0.7 nmol) on extracellular levels of DA within the prefrontal cortex (PFC) and nucleus accumbens (Acc). Electroencephalographic/electromyographic measures of sleep-wake state were collected along with select behavioral measures (eg locomotor activity, grooming). HCRT-1 dose-dependently increased PFC dialysate DA levels, and these increases were closely correlated with increases in time spent awake. In contrast, Acc DA levels were unaffected. Additional studies examined whether HCRT-1 acts directly within the ventral tegmental area (VTA) to selectively increase PFC DA efflux and modulate behavioral state. Unilateral infusion of HCRT-1 (0.1, 1.0 nmol) within the VTA increased PFC, but not Acc, DA levels. Importantly, intra-VTA infusion of HCRT-1 increased the time spent awake and grooming. Moreover, HCRT-induced increases in both time spent awake and time spent grooming were significantly correlated with post-infusion PFC DA levels. The current observations predict a prominent modulatory influence of HCRT on PFC-dependent cognitive and affective processes that results, in part, from actions within the VTA. Additionally, these observations suggest that the activation of VTA DA neurons contributes to the behavioral state-modulatory actions of HCRT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15988471     DOI: 10.1038/sj.npp.1300807

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  74 in total

1.  Neuropharmacology of Sleep and Wakefulness.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2010-12

2.  Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.

Authors:  Thorfinn T Riday; Eric W Fish; J Elliott Robinson; Thomas M Jarrett; Megan M McGuigan; C J Malanga
Journal:  Brain Res       Date:  2011-11-07       Impact factor: 3.252

Review 3.  Hypocretin/orexin involvement in reward and reinforcement.

Authors:  Rodrigo A España
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

4.  Antagonism of orexin 1 receptors eliminates motor hyperactivity and improves homing response acquisition in juvenile rats exposed to alcohol during early postnatal period.

Authors:  Georg M Stettner; Leszek Kubin; Denys V Volgin
Journal:  Behav Brain Res       Date:  2011-03-21       Impact factor: 3.332

5.  The orexin system regulates alcohol-seeking in rats.

Authors:  Andrew J Lawrence; Michael S Cowen; Hong-Ju Yang; Feng Chen; Brian Oldfield
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

6.  Differential effects of acute and chronic ethanol exposure on orexin expression in the perifornical lateral hypothalamus.

Authors:  Irene Morganstern; Guo-Q Chang; Jessica R Barson; Zhiyu Ye; Olga Karatayev; Sarah F Leibowitz
Journal:  Alcohol Clin Exp Res       Date:  2010-03-10       Impact factor: 3.455

Review 7.  Overconsumption of dietary fat and alcohol: mechanisms involving lipids and hypothalamic peptides.

Authors:  Sarah F Leibowitz
Journal:  Physiol Behav       Date:  2007-03-30

8.  Activation of afferents to the ventral tegmental area in response to acute amphetamine: a double-labelling study.

Authors:  Joyce Colussi-Mas; Stefanie Geisler; Luc Zimmer; Daniel S Zahm; Anne Bérod
Journal:  Eur J Neurosci       Date:  2007-08       Impact factor: 3.386

9.  The dopaminergic system of the telencephalo-diencephalic areas of the vertebrate brain in the organization of the sleep-waking cycle.

Authors:  G A Oganesyan; I V Romanova; E A Aristakesyan; V V Kuzik; D M Makina; I Yu Morina; A E Khramenkova; I V Artamokhina; V A Belova
Journal:  Neurosci Behav Physiol       Date:  2009-09-23

Review 10.  Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction.

Authors:  Coleman B Calva; Jim R Fadel
Journal:  Brain Res       Date:  2018-08-24       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.